Shopping Cart 0
Cart Subtotal
USD 0

Bone Therapeutics SA (BOTHE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fractures; and ALLOB, an allogeneic osteoblastic cell therapy product, for delayed-union fractures, spinal fusion procedures, and frevision spinal fusion. Bone Therapeutics conducts preclinical research on next generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications. The company conducts clinical studies for treatment of delayed-union fractures and spinal fusion. Bone Therapeutics is headquartered in Gosselies, Belgium.

Bone Therapeutics SA (BOTHE)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Bone Therapeutics SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Bone Therapeutics SA, Medical Devices Deals, 2012 to YTD 2018 10

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Bone Therapeutics Raises USD 8 Million In Series D Financing Round 12

Partnerships 13

Bone Therapeutics to Enter into Agreement with Cellthera Pharm 13

Bone Therapeutics Extends Agreement with Kasios 14

Licensing Agreements 15

Asahi Kasei Enters into Licensing Agreement with Bone Therapeutics 15

Bone Therapeutics Enters into Licensing Agreement with Enrico Bastianelli 16

Enrico Bastianelli Enters into Licensing Agreement with Bone Therapeutics 17

Bone Therapeutics Enters into Licensing Agreement with Enrico Bastianelli for BONE-011 18

Equity Offering 19

Bone Therapeutics Withdraws Private Placement of Shares 19

Bone Therapeutics Raises USD38 Million in IPO 21

Debt Offering 23

Bone Therapeutics Raises USD24.1 Million in Private Placement of Bonds 23

Bone Therapeutics SA-Key Competitors 24

Bone Therapeutics SA-Key Employees 25

Bone Therapeutics SA-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Recent Developments 27

Financial Announcements 27

Aug 30, 2018: Bone Therapeutics announces H1 results for 2018 27

Apr 25, 2018: Bone Therapeutics Announces Full Year 2017 Financial Results 28

Nov 09, 2017: Bone Therapeutics: Business Update for Third Quarter 2017 29

Aug 31, 2017: Bone Therapeutics Announces H1 Results for 2017 30

May 11, 2017: Bone Therapeutics Business Update for First Quarter 2017 32

Mar 16, 2017: Bone Therapeutics Reports Full Year 2016 Results 33

Jan 17, 2017: Bone Therapeutics Provides Business Update for Q4 2016 34

Corporate Communications 36

Jun 14, 2018: Bone Therapeutics announces results of Annual General Meeting 36

Apr 26, 2018: Bone Therapeutics Appoints Claudia D'Augusta As Non-Executive Director 37

Feb 20, 2018: Bone Therapeutics strengthens Board with the appointment of Jean Stephenne as Chairman 38

Aug 31, 2017: Bone Therapeutics Appoints Jean-Luc Vandebroek as Chief Financial Officer 39

Jul 03, 2017: Bone Therapeutics Strengthens Board of Directors 40

May 29, 2017: Bone Therapeutics: Strengthens Board with the appointments of Steve Swinson and Damian Marron as Non-Executive Directors 42

Mar 06, 2017: Bone Therapeutics Strengthens Clinical Development Leadership with Appointment of Dr. Miguel Forte as Chief Medical Officer 43

Other Significant Developments 44

Jan 23, 2018: Bone Therapeutics provides business outlook and announces its financial calendar for 2018 44

Appendix 45

Methodology 45

About GlobalData 45

Contact Us 45

Disclaimer 45


List Of Figure

List of Figures

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Bone Therapeutics SA, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Bone Therapeutics SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Bone Therapeutics SA, Deals By Therapy Area, 2012 to YTD 2018 9

Bone Therapeutics SA, Medical Devices Deals, 2012 to YTD 2018 10

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Bone Therapeutics Raises USD 8 Million In Series D Financing Round 12

Bone Therapeutics to Enter into Agreement with Cellthera Pharm 13

Bone Therapeutics Extends Agreement with Kasios 14

Asahi Kasei Enters into Licensing Agreement with Bone Therapeutics 15

Bone Therapeutics Enters into Licensing Agreement with Enrico Bastianelli 16

Enrico Bastianelli Enters into Licensing Agreement with Bone Therapeutics 17

Bone Therapeutics Enters into Licensing Agreement with Enrico Bastianelli for BONE-011 18

Bone Therapeutics Withdraws Private Placement of Shares 19

Bone Therapeutics Raises USD38 Million in IPO 21

Bone Therapeutics Raises USD24.1 Million in Private Placement of Bonds 23

Bone Therapeutics SA, Key Competitors 24

Bone Therapeutics SA, Key Employees 25

Bone Therapeutics SA, Subsidiaries 26

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Bone Therapeutics SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fractures; and ALLOB, an allogeneic osteoblastic cell therapy product, for delayed-union fractures, spinal fusion procedures, and frevision spinal fusion. Bone Therapeutics conducts preclinical research on next generation product candidates such as combined cell-matrix products for large bone defects and maxillofacial applications. The company conducts clinical studies for treatment of delayed-union fractures and spinal fusion. Bone Therapeutics is headquartered in Gosselies, Belgium.

Bone Therapeutics SA (BOTHE)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Bone Therapeutics SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Bone Therapeutics SA, Medical Devices Deals, 2012 to YTD 2018 10

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deal Details 12

Venture Financing 12

Bone Therapeutics Raises USD 8 Million In Series D Financing Round 12

Partnerships 13

Bone Therapeutics to Enter into Agreement with Cellthera Pharm 13

Bone Therapeutics Extends Agreement with Kasios 14

Licensing Agreements 15

Asahi Kasei Enters into Licensing Agreement with Bone Therapeutics 15

Bone Therapeutics Enters into Licensing Agreement with Enrico Bastianelli 16

Enrico Bastianelli Enters into Licensing Agreement with Bone Therapeutics 17

Bone Therapeutics Enters into Licensing Agreement with Enrico Bastianelli for BONE-011 18

Equity Offering 19

Bone Therapeutics Withdraws Private Placement of Shares 19

Bone Therapeutics Raises USD38 Million in IPO 21

Debt Offering 23

Bone Therapeutics Raises USD24.1 Million in Private Placement of Bonds 23

Bone Therapeutics SA-Key Competitors 24

Bone Therapeutics SA-Key Employees 25

Bone Therapeutics SA-Locations And Subsidiaries 26

Head Office 26

Other Locations & Subsidiaries 26

Recent Developments 27

Financial Announcements 27

Aug 30, 2018: Bone Therapeutics announces H1 results for 2018 27

Apr 25, 2018: Bone Therapeutics Announces Full Year 2017 Financial Results 28

Nov 09, 2017: Bone Therapeutics: Business Update for Third Quarter 2017 29

Aug 31, 2017: Bone Therapeutics Announces H1 Results for 2017 30

May 11, 2017: Bone Therapeutics Business Update for First Quarter 2017 32

Mar 16, 2017: Bone Therapeutics Reports Full Year 2016 Results 33

Jan 17, 2017: Bone Therapeutics Provides Business Update for Q4 2016 34

Corporate Communications 36

Jun 14, 2018: Bone Therapeutics announces results of Annual General Meeting 36

Apr 26, 2018: Bone Therapeutics Appoints Claudia D'Augusta As Non-Executive Director 37

Feb 20, 2018: Bone Therapeutics strengthens Board with the appointment of Jean Stephenne as Chairman 38

Aug 31, 2017: Bone Therapeutics Appoints Jean-Luc Vandebroek as Chief Financial Officer 39

Jul 03, 2017: Bone Therapeutics Strengthens Board of Directors 40

May 29, 2017: Bone Therapeutics: Strengthens Board with the appointments of Steve Swinson and Damian Marron as Non-Executive Directors 42

Mar 06, 2017: Bone Therapeutics Strengthens Clinical Development Leadership with Appointment of Dr. Miguel Forte as Chief Medical Officer 43

Other Significant Developments 44

Jan 23, 2018: Bone Therapeutics provides business outlook and announces its financial calendar for 2018 44

Appendix 45

Methodology 45

About GlobalData 45

Contact Us 45

Disclaimer 45


List Of Figure

List of Figures

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

Bone Therapeutics SA, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

Bone Therapeutics SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

Bone Therapeutics SA, Deals By Therapy Area, 2012 to YTD 2018 9

Bone Therapeutics SA, Medical Devices Deals, 2012 to YTD 2018 10

Bone Therapeutics SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

Bone Therapeutics Raises USD 8 Million In Series D Financing Round 12

Bone Therapeutics to Enter into Agreement with Cellthera Pharm 13

Bone Therapeutics Extends Agreement with Kasios 14

Asahi Kasei Enters into Licensing Agreement with Bone Therapeutics 15

Bone Therapeutics Enters into Licensing Agreement with Enrico Bastianelli 16

Enrico Bastianelli Enters into Licensing Agreement with Bone Therapeutics 17

Bone Therapeutics Enters into Licensing Agreement with Enrico Bastianelli for BONE-011 18

Bone Therapeutics Withdraws Private Placement of Shares 19

Bone Therapeutics Raises USD38 Million in IPO 21

Bone Therapeutics Raises USD24.1 Million in Private Placement of Bonds 23

Bone Therapeutics SA, Key Competitors 24

Bone Therapeutics SA, Key Employees 25

Bone Therapeutics SA, Subsidiaries 26

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

Bone Therapeutics SA, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.